⌘K

Home/Filings/4/0001437749-23-015335

4//SEC Filing

Bode John B 4

Accession 0001437749-23-015335

CIK 0001434647other

View on SEC.gov Company Profile

Filed

May 18, 8:00 PM ET

Accepted

May 19, 5:53 PM ET

Size

11.1 KB

Accession

0001437749-23-015335

Insider Transaction Report

Form 4

Period: 2023-05-18

ZEVRA THERAPEUTICS, INC.ZVRA

Director

Transactions

Purchase
Common Stock
2023-05-18$5.05/sh+2,451$12,378→ 10,000 total
Purchase
Common Stock
2023-05-18$5.04/sh+1,390$6,999→ 1,390 total
Purchase
Common Stock
2023-05-18$5.04/sh+300$1,512→ 1,690 total
Purchase
Common Stock
2023-05-18$5.04/sh+1,000$5,040→ 2,690 total
Purchase
Common Stock
2023-05-18$5.04/sh+100$505→ 7,549 total
Purchase
Common Stock
2023-05-18$5.04/sh+4,759$23,985→ 7,449 total

Documents

1 file

4
rdgdoc.xmlPrimary
FORM 4

Issuer

ZEVRA THERAPEUTICS, INC.

CIK 0001434647

Entity typeother

Related Parties

1

filerCIK 0001612084

Filing Metadata

Form type: 4
Filed: May 18, 8:00 PM ET
Accepted: May 19, 5:53 PM ET
Size: 11.1 KB

View on SEC.gov